542334
IGEPAL® CO-630
average Mn 617
别名:
聚氧代乙烯(9)壬基苯基醚，支化
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
(C2H4O)n · C15H24O · n=9-10
化学文摘社编号:
UNSPSC Code:
12162002
NACRES:
NA.23
MDL number:
General description
IGEPAL® CO-630 是烷基酚乙氧基化物，主要用作阴离子表面活性剂。 属于IGEPAL系列表面活性剂，含疏水链。具有表面张力低、灵敏度低和生物相容性的特性。
Application
非离子表面活性剂。
Legal Information
IGEPAL is a registered trademark of Solvay
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
signalword
Danger
hcodes
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - ED ENV 1
法规信息
危险化学品
此项目有
Preparation of highly concentrated stable dispersions of uniform silver nanoparticles
Sondi I, et al.
Journal of Colloid and Interface Science, 260(1), 75-81 (2003)
Viktorija Herceg et al.
Molecules (Basel, Switzerland), 25(18) (2020-09-24)
Cyclopeptidic chemotherapeutic prodrugs (cPCPs) are macromolecular protease-sensitive doxorubicin (DOX) prodrugs synthesized from a cyclodecapeptidic scaffold, termed Regioselectively Addressable Functionalized Template (RAFT). In order to increase the chemotherapeutic potential of DOX and limit its toxicity, we used a Cathepsin B (Cat
Mirko Trilling et al.
Journal of virology, 83(8), 3684-3695 (2009-02-13)
Vaccinia virus (VACV) replicates in mouse and human fibroblasts with comparable kinetics and efficiency, yielding similar titers of infectious progeny. Here we demonstrate that gamma interferon (IFN-gamma) but not IFN-alpha or IFN-beta pretreatment of mouse fibroblasts prior to VACV infection
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 542334-1KG-A | 04061835571703 |
| 542334-100G-A | 04061837831737 |